Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency

Virus Research

Volumn 139, Issue 1, 2009, Pages 74-84

  Ohsaki, Eriko ^a   Suzuki, Tohru ^a   Karayama, Masato ^a   Ueda, Keiji ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

KSHV; LANA; Latency; Nuclear matrix; ori P; Replication; Replisome

Indexed keywords

LATENCY ASSOCIATED NUCLEAR ANTIGEN;

ARTICLE; CELL CYCLE G1 PHASE; CELL NUCLEUS MATRIX; CONTROLLED STUDY; DISEASE ASSOCIATION; HERPES VIRUS; HUMAN; HUMAN CELL; KAPOSI SARCOMA; LATENT PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; ANTIGENS, VIRAL; CELL LINE, TUMOR; G1 PHASE; HERPESVIRUS 8, HUMAN; HUMANS; NUCLEAR MATRIX; NUCLEAR PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

EID: 57749121215     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.10.011     Document Type: Article

References (64)

1. Anachkova B., Djeliova V., and Russev G. Nuclear matrix support of DNA replication. J. Cell. Biochem. 96 5 (2005) 951-961
2. Ballestas M.E., Chatis P.A., and Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 5414 (1999) 641-644
3. Bechtel J.T., Liang Y., Hvidding J., and Ganem D. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 77 11 (2003) 6474-6481
4. Bechtel J.T., Winant R.C., and Ganem D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79 8 (2005) 4952-4964
5. Belgrader P., Siegel A.J., and Berezney R. A comprehensive study on the isolation and characterization of the HeLa S3 nuclear matrix. J. Cell. Sci. 98 Pt 3 (1991) 281-291
6. Bell S.P. The origin recognition complex: from simple origins to complex functions. Genes Dev. 16 6 (2002) 659-672
7. Berezney R., Mortillaro M.J., Ma H., Wei X., and Samarabandu J. The nuclear matrix: a structural milieu for genomic function. Int. Rev. Cytol. 162A (1995) 1-65
8. Blow J.J., and Dutta A. Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell Biol. 6 6 (2005) 476-486
9. Boshoff C., and Weiss R.A. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 356 1408 (2001) 517-534
10. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332 18 (1995) 1186-1191
11. Chang Y., and Moore P.S. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect. Agents Dis. 5 4 (1996) 215-222
12. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 5192 (1994) 1865-1869
13. Chaudhuri B., Xu H., Todorov I., Dutta A., and Yates J.L. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. U.S.A. 98 18 (2001) 10085-10089
14. Chen L., and Lagunoff M. Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells. J. Virol. 79 22 (2005) 14383-14391
15. Cook P.R. The organization of replication and transcription. Science 284 5421 (1999) 1790-1795
16. Cook P.R., and Brazell I.A. Supercoils in human DNA. J. Cell. Sci. 19 2 (1975) 261-279
17. Cotter II M.A., and Robertson E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264 2 (1999) 254-264
18. DePamphilis M.L. The 'ORC cycle': a novel pathway for regulating eukaryotic DNA replication. Gene 310 (2003) 1-15
19. DePamphilis M.L., Blow J.J., Ghosh S., Saha T., Noguchi K., and Vassilev A. Regulating the licensing of DNA replication origins in metazoa. Curr. Opin. Cell Biol. 18 3 (2006) 231-239
20. Dhar S.K., Yoshida K., Machida Y., Khaira P., Chaudhuri B., Wohlschlegel J.A., Leffak M., Yates J., and Dutta A. Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106 3 (2001) 287-296
21. Djeliova V., Russev G., and Anachkova B. Dynamics of association of origins of DNA replication with the nuclear matrix during the cell cycle. Nucl. Acids Res. 29 15 (2001) 3181-3187
22. Fejer G., Medveczky M.M., Horvath E., Lane B., Chang Y., and Medveczky P.G. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication. J. Gen. Virol. 84 Pt 6 (2003) 1451-1462
23. Garber A.C., Shu M.A., Hu J., and Renne R. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 17 (2001) 7882-7892
24. Gehmlich K., Haren L., and Merdes A. Cyclin B degradation leads to NuMA release from dynein/dynactin and from spindle poles. EMBO Rep. 5 1 (2004) 97-103
25. Grundhoff A., and Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113 1 (2004) 124-136
26. Hu J., and Renne R. Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J. Virol. 79 4 (2005) 2637-2642
27. Hu J., Garber A.C., and Renne R. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76 22 (2002) 11677-11687
28. Jackson D.A., and Cook P.R. The structural basis of nuclear function. Int. Rev. Cytol. 162A (1995) 125-149
29. Jenke A.C.W., Stehle I.M., Herrmann F., Eisenberger T., Baiker A., Bode J., Faclelmayer F.O., and Lipps H.J. Nuclear scaffold/matrix attached region modules linked to a transcritption unit are sufficient for replication and maintenance of a mammalian genome. Proc. Natl. Acad. Sci. U.S.A. 101 31 (2004) 11322-11327
30. Kelley-Clarke B., Ballestas M.E., Komatsu T., and Kaye K.M. Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes. Virology 357 2 (2007) 149-157
31. Kitamura E., Blow J.J., and Tanaka T.U. Live-cell imaging reveals replication of individual replicons in eukaryotic replication factories. Cell 125 7 (2006) 1297-1308
32. Komatsu T., Ballestas M.E., Barbera A.J., Kelley-Clarke B., and Kaye K.M. KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology 319 2 (2004) 225-236
33. Lagunoff M., Bechtel J., Venetsanakos E., Roy A.M., Abbey N., Herndier B., McMahon M., and Ganem D. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 76 5 (2002) 2440-2448
34. Laman H., Peters G., and Jones N. Cyclin-mediated export of human Orc1. Exp. Cell Res. 271 2 (2001) 230-237
35. Leonhardt H., Rahn H.P., Weinzierl P., Sporbert A., Cremer T., Zink D., and Cardoso M.C. Dynamics of DNA replication factories in living cells. J. Cell Biol. 149 2 (2000) 271-280
36. Li C.J., and DePamphilis M.L. Mammalian Orc1 protein is selectively released from chromatin and ubiquitinated during the S-to-M transition in the cell division cycle. Mol. Cell Biol. 22 1 (2002) 105-116
37. Lim C., Sohn H., Lee D., Gwack Y., and Choe J. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J. Virol. 76 20 (2002) 10320-10331
38. Mattia E., Ceridono M., Chichiarelli S., and D'Erme M. Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection. Virology 262 1 (1999) 9-17
39. McNairn A.J., Okuno Y., Misteli T., and Gilbert D.M. Chinese hamster ORC subunits dynamically associate with chromatin throughout the cell-cycle. Exp. Cell Res. 308 2 (2005) 345-356
40. Mika S., and Rost B. NMPdb: database of nuclear matrix proteins. Nucl. Acids Res. 33 (2005) D160-D163 (Database Issue)
41. Nakayasu H., and Berezney R. Mapping replicational sites in the eucaryotic cell nucleus. J. Cell Biol. 108 1 (1989) 1-11
42. Neri L.M., Mazzotti G., Capitani S., Maraldi N.M., Cinti C., Baldini N., Rana R., and Martelli A.M. Nuclear matrix-bound replicational sites detected in situ by 5-bromodeoxyuridine. Histochemistry 98 1 (1992) 19-32
43. Numazaki K., Chiba S., Aoki K., Suzuki K., and Ohno S. Human herpesvirus 8 variants. Lancet 351 9103 (1998) 680
44. Ohsaki E., Ueda K., Sakakibara S., Do E., Yada K., and Yamanishi K. Poly (ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J. Virol. 78 18 (2004) 9936-9946
45. Ohta S., Tatsumi Y., Fujita M., Tsurimoto T., and Obuse C. The ORC1 cycle in human cells. II. Dynamic changes in the human ORC complex during the cell cycle. J. Biol. Chem. 278 42 (2003) 41535-41540
46. Okuno Y., McNairn A.J., den Elzen N., Pines J., and Gilbert D.M. Stability, chromatin association and functional activity of mammalian pre-replication complex proteins during the cell cycle. EMBO J. 20 15 (2001) 4263-4277
47. Pardoll D.M., Vogelstein B., and Coffey D.S. A fixed site of DNA replication in eucaryotic cells. Cell 19 2 (1980) 527-536
48. Payrastre B., Nievers M., Boonstra J., Breton M., Verkleij A.J., and Van Bergen en Henegouwen P.M. A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. J. Biol. Chem. 267 8 (1992) 5078-5084
49. Radichev I., Parashkevova A., and Anachkova B. Initiation of DNA replication at a nuclear matrix-attached chromatin fraction. J. Cell. Physiol. 203 1 (2005) 71-77
50. Radichev I., Kwon S.W., Zhao Y., DePamphilis M.L., and Vassilev A. Genetic analysis of human Orc2 reveals specific domains that are required in vivo for assembly and nuclear localization of the origin recognition complex. J. Biol. Chem. 281 32 (2006) 23264-23273
51. Reyes J.C., Muchardt C., and Yaniv M. Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol. 137 2 (1997) 263-274
52. Ritzi M., Tillack K., Gerhardt J., Ott E., Humme S., Kremmer E., Hammerschmidt W., and Schepers A. Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus. J. Cell Sci. 116 Pt 19 (2003) 3971-3984
53. Sakakibara S., Ueda K., Nishimura K., Do E., Ohsaki E., Okuno T., and Yamanishi K. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J. Virol. 78 14 (2004) 7299-7310
54. Schepers A., Ritzi M., Bousset K., Kremmer E., Yates J.L., Harwood J., Diffley J.F., and Hammerschmidt W. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 20 16 (2001) 4588-4602
55. Si H., Verma S.C., Lampson M.A., Cai Q., and Robertson E.S. Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation. J. Virol. 82 13 (2008) 6734-6746
56. Stedman W., Deng Z., Lu F., and Lieberman P.M. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J. Virol. 78 22 (2004) 12566-12575
57. Sugden B. In the beginning: a viral origin exploits the cell. Trends Biochem. Sci. 27 1 (2002) 1-3
58. Sun W.H., Coleman T.R., and DePamphilis M.L. Cell cycle-dependent regulation of the association between origin recognition proteins and somatic cell chromatin. EMBO J. 21 6 (2002) 1437-1446
59. Takayama M., Taira A.T., Tamai K., Iguchi-Ariga S.M., and Ariga H. ORC1 interacts with c-myc to inhibit E-box-dependent transcription by abrogating c-Myc-SNF5/INI1 interaction. Genes Cells 5 (2000) 481-490
60. Ueda K., Sakakibara S., Ohsaki E., and Yada K. Lack of a mechanism for faithful partition and maintenance of the KSHV genome. Virus Res. 122 1-2 (2006) 85-94
61. Vashee S., Cvetic C., Lu W., Simancek P., Kelly T.J., and Walter J.C. Sequence-independent DNA binding and replication initiation by the human origin recognition complex. Genes Dev. 17 15 (2003) 1894-1908
62. Verma S.C., Choudhuri T., Kaul R., and Robertson E.S. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J. Virol. 80 5 (2006) 2243-2256
63. Vogelstein B., Pardoll D.M., and Coffey D.S. Supercoiled loops and eucaryotic DNA replication. Cell 22 1 Pt 1 (1980) 79-85
64. Wei X., Somanathan S., Samarabandu J., and Berezney R. Three-dimensional visualization of transcription sites and their association with splicing factor-rich nuclear speckles. J. Cell Biol. 146 3 (1999) 543-558